Determinants of Intradialytic Phosphate Removal in Hemodiafiltration From Real‐World Clinical Practice
Artificial Organs · 2026
DOI: 10.1111/aor.70104 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Artificial Organs, 2026. Verfasst von David A Jaques und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Geneva University Hospitals, Geneva, Switzerland. Hauptthemen laut MEDLINE: Hemodiafiltration, Phosphates, Hyperphosphatemia, Kidney Failure, Chronic. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Hyperphosphatemia is frequent in hemodialysis (HD) patients and associates with cardiovascular mortality. Parameters of online hemodiafiltration (OL‐HDF) prescription influencing phosphate removal are poorly understood in real‐world clinical settings.
Methods
We conducted a prospective observational study including chronic HD patients dialyzed at a single UK university hospital between December 2021 and July 2023. Phosphate removal was quantified from spent dialysate during a midweek session.
Results
Dialysate phosphate was measured during 161 dialysis sessions in 128 unique patients (19 on HD and 109 on OL‐HDF), with mean age 63.3 ± 16.2 years and 77 (60.1%) men. Mean intra‐dialytic phosphate removal was 25.6 ± 14.3 mmol per session. In multivariate analysis, pre‐HD serum phosphate concentration, session time, and urea distribution volume ( V ) were positively associated with intradialytic phosphate removal. A significant interaction between session time and pre‐HD serum phosphate concentration indicated that longer sessions provided greater benefit to patients with higher baseline phosphate levels. Conversely, dialysis modality (OL‐HDF vs. HD) and substitution volume were not significantly associated with phosphate removal.
Conclusions
OL‐HDF and substitution flow do not demonstrate a measurable beneficial impact on phosphate removal in a real‐world setting. Session time, pre‐HD serum phosphate concentration, and urea distribution volume ( V ) are the most relevant determinants of phosphate clearance in real‐world clinical practice. Session duration emerges as the most effective modifiable factor for controlling phosphate burden in dialysis patients, particularly for those with higher pre‐HD phosphate levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Geneva University Hospitals, Geneva, Switzerland.
- UCL Division of Medicine, University College London, London, UK.
- Clinical Nutrition Department, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Medicine, Alexandra Hospital, Singapore, Singapore.
- UCL Centre for Kidney & Bladder Health, Royal Free Hospital, University College London, London, UK.
ORCID-Profile: David A Jaques, Priyanka Khatri
Zitieren
APA
Jaques, D. A., Chhabra, R., Shaaker, H., Khatri, P., & Davenport, A. (2026). Determinants of Intradialytic Phosphate Removal in Hemodiafiltration From Real‐World Clinical Practice. Artificial Organs. https://doi.org/10.1111/aor.70104
Vancouver
Jaques DA, Chhabra R, Shaaker H, Khatri P, Davenport A. Determinants of Intradialytic Phosphate Removal in Hemodiafiltration From Real‐World Clinical Practice. Artificial Organs. 2026. doi:10.1111/aor.70104
BibTeX
@article{Jaques2026,
author = {Jaques, David A and Chhabra, Roohi and Shaaker, Haalah and Khatri, Priyanka and Davenport, Andrew},
title = {Determinants of Intradialytic Phosphate Removal in Hemodiafiltration From Real‐World Clinical Practice},
journal = {Artificial Organs},
year = {2026},
doi = {10.1111/aor.70104}
}
EUVIMED